5MGE
Crystal structure of BAZ2B bromodomain in complex with 1-methylpyridine derivative 1
5MGE の概要
| エントリーDOI | 10.2210/pdb5mge/pdb |
| 分子名称 | Bromodomain adjacent to zinc finger domain protein 2B, ethyl 4-chloranyl-1-methyl-6-oxidanylidene-pyridine-3-carboxylate (3 entities in total) |
| 機能のキーワード | four helical bundle, transcription |
| 由来する生物種 | Homo sapiens (Human) |
| 細胞内の位置 | Nucleus : Q9UIF8 |
| タンパク質・核酸の鎖数 | 1 |
| 化学式量合計 | 13747.21 |
| 構造登録者 | |
| 主引用文献 | Spiliotopoulos, D.,Wamhoff, E.C.,Lolli, G.,Rademacher, C.,Caflisch, A. Discovery of BAZ2A bromodomain ligands. Eur J Med Chem, 139:564-572, 2017 Cited by PubMed Abstract: The bromodomain adjacent to zinc finger domain protein 2A (BAZ2A) is implicated in aggressive prostate cancer. The BAZ2A bromodomain is a challenging target because of the shallow pocket of its natural ligand, the acetylated side chain of lysine. Here, we report the successful screening of a library of nearly 1500 small molecules by high-throughput docking and force field-based binding-energy evaluation. For seven of the 20 molecules selected in silico, evidence of binding to the BAZ2A bromodomain is provided by ligand-observed NMR spectroscopy. Two of these compounds show a favorable ligand efficiency of 0.42 kcal/mol per non-hydrogen atom in a competition-binding assay. The crystal structures of the BAZ2A bromodomain in complex with four fragment hits validate the predicted binding modes. The binding modes of compounds 1 and 3 are compatible with ligand growing for optimization of affinity for BAZ2A and selectivity against the close homologue BAZ2B. PubMed: 28837921DOI: 10.1016/j.ejmech.2017.08.028 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.95 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






